nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A high cardiothoracic ratio increases the risk of severe pulmonary complications after early initiation of clazosentan in patients with aneurysmal subarachnoid hemorrhage
|
Nishii, Rikuo |
|
|
5 |
2 |
p. 85-90 |
artikel |
2 |
Beneficial effects of clazosentan add-on treatment on delayed cerebral microcirculatory disturbances after aneurysmal subarachnoid hemorrhage
|
Suzuki, Hidenori |
|
|
5 |
2 |
p. 62-68 |
artikel |
3 |
Clazosentan, first approval in Japan: Has perioperative management of subarachnoid hemorrhage changed?
|
Suzuki, Hidenori |
|
|
5 |
2 |
p. 53-54 |
artikel |
4 |
Could clazosentan, first approved in Japan, improve neurological prognosis after subarachnoid hemorrhage in combination with modified water-electrolyte management?
|
Shikata, Eiji |
|
|
5 |
2 |
p. 91-97 |
artikel |
5 |
Evolving approaches in the management of patients with subarachnoid hemorrhage from 2002 to 2022: The impact of clazosentan and treatment modalities on outcomes
|
Maeda, Hajime |
|
|
5 |
2 |
p. 55-61 |
artikel |
6 |
Fluid balance management with loop diuretics in patients with aneurysmal subarachnoid hemorrhage treated with clazosentan: A case series
|
Akamatsu, Yosuke |
|
|
5 |
2 |
p. 74-78 |
artikel |
7 |
Impact of strict fluid management on the treatment outcome of clazosentan for cerebral vasospasm
|
Itazu, Takaaki |
|
|
5 |
2 |
p. 69-73 |
artikel |
8 |
Initial results of clazosentan with multiple-drug management for the prevention of cerebral vasospasm after aneurysmal subarachnoid hemorrhage
|
Kimura, Tatsuki |
|
|
5 |
2 |
p. 79-84 |
artikel |